Shohei Andoh¹, Junya Makiyama¹, Mai Mizusawa¹, Kanya Kondoh¹, Toyotaka Kawamata¹, Kazuaki Yokoyama¹, Tomohiko Koibuchi², Hiroshi Yasui¹, Yasunori Ota³, Yoichi Imai¹, Hiroshi Yotsuyanagi², Arinobu Tojo¹ (1.Department of Hematology / Oncology, IMSUT hospital, Tokyo, Japan., 2.Department of Infectious Diseases and Applied Immunology, IMSUT hospital., 3.Department of Pathology and Laboratory Medicine, IMSUT hospital.)

Shotaro Hagiwara¹, Masayuki Shiseki¹, Kentaro Yoshinaga¹, Junji Tanaka¹, Seiji Okada² (1.Hematol, Tokyo Women's Medical University, Japan, 2.AIDS Research Center Kumamoto University, Japan)

Daisuke Kaji^1,2, Michiho Ebihara¹, Mitsuhiro Yuasa¹, Kosei Kageyama¹, Aya Nishida¹, Shinsuke Takagi¹, Hisashi Yamamoto¹, Yuki Asano-Mori¹, Naoyuki Uchida¹, Yasunori Ota³, Koji Izutsu^1,4, Shigeru Chiba⁵, Shuichi Taniguchi¹, Go Yamamoto¹ (1.Department of Hematology, Toranomon Hospital, Tokyo, Japan, 2.Hematology, Graduate School of Comprehensive Human Sciences, University of Tsukuba, 3.Department of Pathology, The University of Teikyo, Tokyo, Japan, 4.Department of Hematology, National Cancer Center Hospital, Tokyo, Japan, 5.Department of Hematology, University of Tsukuba, Tsukuba, Japan)

Ferania Mella¹, Yasuhiro Yamashiro¹, Yuki Amao¹, Fukumi Ohto¹, Shizuka Ogata¹, Kazuhiko Muraki², Naoki Fujita², Junko Okita³, Yukiko Torii³, Yukio Hattori³ (1.Ube, Japan, 2.Internal Medicine Department, Yamaguchi Saisekai General Hospital, Yamaguchi, Japan, 3.Inspection Department, Yamaguchi Saisekai General Hospital, Yamaguchi, Japan)

Hui-Hua Hsiao¹, Yu-Fen Tsai¹, Jeng-Shiun Du¹, Ming-Hui Lin¹, Shih-Hao Tang¹, Hui-Ching Wang¹, Shih-Feng Cho^1,2, Chiung-Tang Huang¹, Jui-Feng Hsu¹, Yi-Chang Liu^1,2, Samuel Y Hsiao¹, Chia-Yen Dai^1,2, Ming-Lung Yu^1,2, Ta-Chih Liu^1,2 (1.Internal Medicine Department, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan, 2.Faculty of Medicine, Kaohiung Medical University, Kaohsiung, Taiwan)

Takaaki Chou¹, Kazuhito Yamamoto², Toshihiko Doi³, Yasuhito Terui⁴, Harumi Kato², Takayuki Hirose¹, Sachiko Seo⁵, Yumi Ogaki⁶, Hiroshi Fujimoto⁶, Tomoko Ohtsu⁶, Kiyohiko Hatake⁷ (1.Department of Hematology Oncology, Niigata Cancer Center Hospital, Niigata, Japan, 2.Department of Hematology and Cell Therapy, Aichi Cancer Center Hospital, Nagoya, Japan, 3.Department of Experimental Therapeutics, National Cancer Center Hospital East, Chiba, Japan, 4.Department of Hematology Oncology, The Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan, 5.Department of Hematology and Oncology, National Cancer Center Hospital East, Chiba, Japan, 6.Celgene K. K., Tokyo, Japan, 7.Department of Hematology, International University of Health and Welfare, Mita, Tokyo, Japan)